About Partners Intelligence Log in →
Connecting Israeli Defense Tech to US Needs
Log in

Oxitone Medical

World-first FDA-cleared wrist pulse-oximeter with AI continuous-monitoring analytics

Israel
11-50

Latest event found: 14 Jul 2026 · 3 months ago

Vitality Radar

47
Current
6M History
Industry
Updated 7 days ago

Pillar Analysis

Presence
The analyst’s view of digital footprint. Shown for context; not part of the score.
52
Business
Dated funding, customer wins, partnerships and acquisitions made, less down rounds, litigation and regulatory action.
55
Innovation
Dated product launches and regulatory clearances, less products retired.
insufficient evidence
Pulse
Direction: dated events in the last 90 days against the 90 before. 50 is flat.
64
Capacity
Dated hiring, leadership hires, expansion and certifications, less layoffs, departures and closures.
0

Strategic Assessment

Strategic Vector

Oxitone is pursuing a focused remote-patient-monitoring strategy built around an FDA-cleared wrist-worn pulse oximeter, continuous vital-sign monitoring, and AI-enabled chronic-care workflows. Public evidence indicates ongoing commercialization but limited recent disclosure of growth, financing, or customer expansion.

Efficiency Ratio

A small team appears to support FDA-cleared hardware, patented sensing technology, international operations, and reported hospital deployments, suggesting strong technical leverage but constrained organizational depth.

Evidence Signals

1 negative signal
Customer Win HIGH IMPACT LOW CONF 14 Jul 2026

Leon Eisen stated that Oxitone had sold its product to more than one hundred hospitals and healthcare enterprises in the United States.

View source United States
Funding MEDIUM IMPACT LOW CONF 14 Jul 2026

Leon Eisen stated that Oxitone had raised more than twenty million dollars over its history, exceeding third-party databases’ commonly reported totals.

View source
Executive Departure HIGH IMPACT LOW CONF 14 Jul 2026

Leon Eisen announced that he was leaving Oxitone after sixteen years, following eleven years as CEO and five years as chairman.

View source Israel

About
Israeli wearables/digital-health company (HQ Kfar Saba, Israel; originated in the Israel Innovation Authority's Ashkelon incubator), founded in 2010 by Dr. Leon Eisen (PhD physics, Weizmann). Its Oxitone 1000M is the world's first FDA-cleared wrist pulse-oximetry medical monitor that works without a fingertip probe — patented 'FlexSense' biosensors embrace the wrist's ulnar bone to read SpO2, pulse, HRV, skin temperature and motion every second, with the VitalsTone AI engine deriving hypoxia, apnea, activity, sleep and physiological-stress indices and flagging deterioration. Targeted at continuous remote care for severe chronic/complex patients; integrated by Ascom for hospital COVID monitoring. The passive continuous-vitals + deterioration-alerting model maps to the casualty-monitoring / prolonged-field-care thread of C12. Defense relevance is commercial-first.
Tags
#wearable #pulseoximetry #spo2 #wrist #rpm #vitals #ai #fda #chroniccare

Suggest an edit

Footer

Connecting Israeli Defense Tech to US Needs

Powered by Meschonomy

Terms Privacy Contact